These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 8748703)
1. In vivo metabolites of N omega-nitro-L-arginine methyl ester: methanol and N omega-nitro-L-arginine. Brouillet E; Roeda D; Valette H; Fuseau C; Guyot MC; Crouzel C Eur J Pharmacol; 1995 Dec; 293(4):487-90. PubMed ID: 8748703 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vivo distribution of no-carrier-added N(omega)-Nitro-L-arginine [11C]methyl ester, a nitric oxide synthase inhibitor. Roeda D; Crouzel C; Brouillet E; Valette H Nucl Med Biol; 1996 May; 23(4):509-12. PubMed ID: 8832708 [TBL] [Abstract][Full Text] [Related]
3. Substantial regional and hemispheric differences in brain nitric oxide synthase (NOS) inhibition following intracerebroventricular administration of N omega-nitro-L-arginine (L-NA) and its methyl ester (L-NAME). Salter M; Duffy C; Garthwaite J; Strijbos PJ Neuropharmacology; 1995 Jun; 34(6):639-49. PubMed ID: 7566500 [TBL] [Abstract][Full Text] [Related]
4. Comparative effects of N omega-nitro-L-arginine and N omega-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, bradykinin, and substance P. Santiago JA; Garrison EA; Kadowitz PJ Eur J Pharmacol; 1994 Mar; 254(3):207-12. PubMed ID: 7516884 [TBL] [Abstract][Full Text] [Related]
5. In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation. Zappellini A; Teixeira SA; Muscará MN; Zatz R; Antunes E; De Nucci G Eur J Pharmacol; 1996 Dec; 317(2-3):285-91. PubMed ID: 8997612 [TBL] [Abstract][Full Text] [Related]
6. Marked variation in responses to long-term nitric oxide inhibition during pregnancy in outbred rats from two different colonies. Buhimschi IA; Shi SQ; Saade GR; Garfield RE Am J Obstet Gynecol; 2001 Mar; 184(4):686-93. PubMed ID: 11262473 [TBL] [Abstract][Full Text] [Related]
7. Influence of N omega-nitro-L-arginine methyl ester, LY83583, glybenclamide and L158809 on pulmonary circulation. Feng CJ; Cheng DY; Kaye AD; Kadowitz PJ; Nossaman BD Eur J Pharmacol; 1994 Sep; 263(1-2):133-40. PubMed ID: 7821344 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine. Pfeiffer S; Leopold E; Schmidt K; Brunner F; Mayer B Br J Pharmacol; 1996 Jul; 118(6):1433-40. PubMed ID: 8832069 [TBL] [Abstract][Full Text] [Related]
9. Distribution and metabolism of NG-nitro-L-arginine and NG-nitro-L-arginine methylester in canine blood in vitro. Krejcy K; Schwarzacher S; Raberger G Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):342-5. PubMed ID: 7683116 [TBL] [Abstract][Full Text] [Related]
10. Chronic administration of a nitric oxide synthase inhibitor, N omega-nitro-L-arginine, and drug-induced increase in cerebellar cyclic GMP in vivo. Bansinath M; Arbabha B; Turndorf H; Garg UC Neurochem Res; 1993 Oct; 18(10):1063-6. PubMed ID: 7504789 [TBL] [Abstract][Full Text] [Related]
11. N(G)-nitro-L-arginine and its methyl ester inhibit brain synthesis of kynurenic acid possibly via nitric oxide-independent mechanism. Luchowski P; Kocki T; Urbańska EM Pol J Pharmacol; 2001; 53(6):597-604. PubMed ID: 11985333 [TBL] [Abstract][Full Text] [Related]
12. Delayed gastric emptying induced by inhibitors of nitric oxide synthase in rats. Plourde V; Quintero E; Suto G; Coimbra C; Taché Y Eur J Pharmacol; 1994 Apr; 256(2):125-9. PubMed ID: 7519557 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective efficacy of N omega-nitro-L-arginine after focal cerebral ischemia in the mouse and inhibition of cortical nitric oxide synthase. Carreau A; Duval D; Poignet H; Scatton B; Vigé X; Nowicki JP Eur J Pharmacol; 1994 May; 256(3):241-9. PubMed ID: 7519148 [TBL] [Abstract][Full Text] [Related]
14. The nitric oxide synthase inhibitor L-NAME (N omega-nitro-L-arginine methyl ester) does not produce discriminative stimulus effects similar to ethanol. Green KL; Gatto GJ; Grant KA Alcohol Clin Exp Res; 1997 May; 21(3):483-8. PubMed ID: 9161609 [TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle and jejunal protein synthesis in normal and ethanol-treated rats: the effect of the nitric oxide synthase inhibitors, L-omega-nitro-L-arginine methyl ester and N(G)-nitro-L-arginine in vivo. Rajendram R; Marway JS; Mantle D; Peters TJ; Preedy VR Metabolism; 2003 Apr; 52(4):397-401. PubMed ID: 12701048 [TBL] [Abstract][Full Text] [Related]
16. Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses. Bryant CE; Allcock GH; Warner TD Br J Pharmacol; 1995 Apr; 114(8):1673-9. PubMed ID: 7541283 [TBL] [Abstract][Full Text] [Related]
17. N omega-nitro-L-arginine methyl ester prevents cerebral hyperemia by inhaled anesthetics in dogs. McPherson RW; Kirsch JR; Moore LE; Traystman RJ Anesth Analg; 1993 Nov; 77(5):891-7. PubMed ID: 8214724 [TBL] [Abstract][Full Text] [Related]
18. Vasomotor responses of canine coronary arterial rings to NG-monomethyl-L-arginine and N omega nitro L-arginine methyl ester. Winn MJ; Asante NK; Ku DD J Pharmacol Exp Ther; 1993 Jan; 264(1):265-70. PubMed ID: 8423529 [TBL] [Abstract][Full Text] [Related]
19. Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice. Suda O; Tsutsui M; Morishita T; Tanimoto A; Horiuchi M; Tasaki H; Huang PL; Sasaguri Y; Yanagihara N; Nakashima Y Circulation; 2002 Sep; 106(13):1729-35. PubMed ID: 12270870 [TBL] [Abstract][Full Text] [Related]
20. Methylesters of L-arginine and N-nitro-L-arginine induce nitric oxide synthase in Staphylococcus aureus. Choi WS; Seo DW; Chang MS; Han JW; Hong SY; Paik WK; Lee HW Biochem Biophys Res Commun; 1998 May; 246(2):431-5. PubMed ID: 9610378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]